Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including astrocytes; strongest in epididymal principal cells | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 11975
Sealed predictions
- OGFOD2 in dopamine neurons, braakn/a → n/areceipt 11982
- OGFOD2 in astrocytes, braakn/a → n/areceipt 11981
Swarm cases
receipt 11982: OGFOD2 in dopamine neurons, braak
- cell type
- OGFOD2 is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for OGFOD2 in dopamine neurons.
case closed: nothing better to follow up.
receipt 11981: OGFOD2 in astrocytes, braak
- cell type
- OGFOD2 is not measured in astrocytes; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for OGFOD2 in astrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts